Log In
BCIQ
Print this Print this
 

ASP8477

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionInhibition of central sensitization
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today